Emerging biomarkers: new directions and clinical applications.
This article summarizes content proceedings of a symposium held at the 2004 Research Society on Alcoholism Scientific Annual Meeting in Vancouver, Canada. The chairs were Friedrich M. Wurst and Raye Litten. The presentations were (1) Introduction, by Raye Litten; (2) Direct Ethanol Metabolites--On the Threshold From Science to Routine Use, by Friedrich M. Wurst; (3) Sialic Acid Index of Plasma Apolipoprotein J (SIJ) as a Viable Marker for Chronic Alcohol Consumption, by Philippe Marmillot; (4) The Emergence of Ethyl Glucuronide (EtG) Testing as a Tool in Monitoring Healthcare Professionals, by Gregory E. Skipper; (5) Application of Biomarkers for Alcohol Use Disorders in Clinical Practice, by Tim Neumann; (6) Utility of Biomarkers in Assessing the Efficacy of Medications for Treating Alcoholism, by Marty Javors; and (7) Discussion, by Raye Litten.
Wurst
Friedrich M
FM
Psychiatric University Hospital, Wilhelm Klein Strasse 27, CH 4025 Basel, Switzerland. friedrich.wurst@pukbasel.ch
Alling
Christer
C
Aradottir
Steina
S
Pragst
Fritz
F
Allen
John P
JP
Weinmann
Wolfgang
W
Marmillot
Phillipe
P
Ghosh
Pradeep
P
Lakshman
Raj
R
Skipper
Gregory E
GE
Neumann
Tim
T
Spies
Claudia
C
Javors
Martin
M
Johnson
Bankole A
BA
Ait-Daoud
Nassima
N
Akhtar
Fatema
F
Roache
John D
JD
Litten
Raye
R
D000437:Alcoholism / Q000175:diagnosis* / Q000378:metabolism* / Q000534:rehabilitation; D015415:Biomarkers; D051152:Clusterin; D020719:Glucuronides / Q000097:blood; D006023:Glycoproteins / Q000097:blood; D006801:Humans; D018832:Molecular Chaperones / Q000097:blood; D008991:Monitoring, Physiologic; D016896:Treatment Outcome
D015415:Biomarkers; C495242:CLU protein, human; D051152:Clusterin; D020719:Glucuronides; D006023:Glycoproteins; D018832:Molecular Chaperones